OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia

• Hiroyuki Kiriyama, MD,
• Junichi Ishida, MD,
• Hiroshi Kadowaki, MD,
• Takeshi Iwasa, MD,
• Arihiro Kiyosue, MD,
• Satoshi Kodera, MD,
• Jiro Ando, MD,
• Hiroshi Akazawa, MD,
• Issei Komuro, MD

Affiliations

Hiroyuki Kiriyama, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan; Address for correspondence: Dr. Hiroyuki Kiriyama, Department of Cardiovascular Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Junichi Ishida, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan

Hiroshi Kadowaki, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan

Takeshi Iwasa, MD

Department of General Internal Medicine, National Cancer Center Hospital, Tokyo, Japan

Arihiro Kiyosue, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan

Satoshi Kodera, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan

Jiro Ando, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan

Hiroshi Akazawa, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan

Issei Komuro, MD

Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, Japan